Anti-HIV-1 activity of an ionically modified porous polypropylene membrane determined by filtration of a viral suspension

Microbiology and Immunology

Volumn 43, Issue 2, 1999, Pages 141-151

  Owada, Takashi ^a,b,c   Miyashita, Yuko ^a   Motomura, Tadahiro ^a   Onishi, Makoto ^a   Yamashita, Shuzo ^a   Yamamoto, Naoki ^b  

^a Department of New Materials Section   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c JAPANESE RED CROSS SOCIETY   (Japan)

Author keywords

Anti viral activity; Filtration; HIV 1 (human immunodeficiency virus type 1); Ionically modified membrane; Potential

Indexed keywords

GAG PROTEIN; POLYETHYLENEIMINE; POLYPROPYLENE;

ANTIVIRAL ACTIVITY; ARTICLE; ELECTRIC POTENTIAL; FILTRATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEMBRANE FILTER; NONHUMAN; VIRUS ADSORPTION; VIRUS CELL INTERACTION; VIRUS INFECTIVITY;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0033034272     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.1999.tb02385.x     Document Type: Article

References (39)

1. Aloia, R.C., Jensen, F.C., Curtain, C.C., Mobley, P.W., and Gordon, L.M. 1988. Lipid composition and fluidity of the human immunodeficiency virus. Proc. Natl. Acad. Sci. U.S.A. 85: 900-904.
2. Baba, M., Patiwels, R., Balzarini, J., Arnout, J., Desmyster, J., and DeClercq, E. 1988. Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro. Proc. Natl. Acad. Sci. U.S.A. 85: 6132-6136.
3. Bagnarelli, P., Candela, M., Valenza, A., Manzin, A., Solforosi, L., Mazzola, F., Butini, L., Montroni, M., Gabrielli, A., Varaldo, P.E., and Clementi, M. 1997. Dynamic features of human immunodeficiency virus type 1 (HIV-1) viremia: kinetics of cell-free HIV-1 RNA after therapeutic plasma exchange. J. Infect. Dis. 176: 801-804.
4. Barre-Sinoussi, F., Chermann, J.C., Key, F., Nugeyre, M.T., Chamaret, S., Gruest, J., Dauguet, C., Axler-Blin, C., Brun-Vezinet, F. Rouzioux, C., Rzenbaum, W., and Montagnier, L. 1983. Isolation of a T-lymphotropic retrovirus from a patient at a risk for acquired immune deficiency syndrome (AIDS). Science 220: 868-871.
5. Bentz, J., Nir, S., and Covell, D.G. 1988. Mass action kinetics of virus-cell aggregation and fusion. Biophys. J. 54: 449-462.
6. Broxton, P., and Woodcock, T. 1983. A study of the antibacterial activity of some polyhexamethylene biguanides towards Escherichia coli ATCC 8739. J. Appl. Bacteriol. 54: 345-353.
7. Clavel, F., Guetard, D., Brun-Vezinet, F., Chamaret, S., Rey, M.-A., Santos-Ferreira, M.O., Laurent, A.G., Dauguet, C., Katlama, C., Rouzioux, C., Klutzmann, D., Champalimaud, J.L., and Montagnier, L. 1986. Isolation of a new human retrovirus from West African patients with AIDS. Science 233: 343-346.
8. Dalgleish, A.G., Beverly, P.C.L., Clapham, P.R., Crawford, D.H., Greaves, M.F., and Weiss, R.A. 1984. The CD4 (T-4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312: 763-766.
9. Davies, A., Bentley, M., and Field, B.S. 1968. Comparison of the action of vantocil, cetrimide and chlorhexidine on Escherichia coli and its spheroplasts and the protoplasts of gram positive bacteria. J. Appl. Bacteriol. 31: 448-461.
10. Duesberg, P.H. 1991. AIDS epidemiology: inconsistencies with human immunodeficiency virus and with infectious disease. Proc. Natl. Acad. Sci. U.S.A. 88: 1575-1579.
11. Freiser, H., and Fernando, Q. 1963. Ionic equilibria in analytical chemistry, chap. 3. Wiley, New York.
12. Fritz, J.S., and Hammond, G.S. 1957. Quantitative organic analysis, chap. 3, Wiley, New York.
13. Gallo, R.C., Salahuddin, S.Z., Popovic, M., Shearer, G.M., Kaplan, M., Haynes, B.F., Palker, T.J., Redfield, R., Oleske, J., Saafai, B., White, G., Foster, P., and Markham, P.D. 1984. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS. Science 224: 500-503.
14. Ho, D.D., Moudgil, T., and Alam, M. 1989. Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. N. Engl. J. Med. 321: 1621-1625.
15. Ho, D.D., Neumann, A.U., Perelson, A.S., Chen, W., Leonard, J.M., and Markowitz, M. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373: 123-126.
16. Ikeda, T., and Hirayama, H. 1986. Polycationic biocides with pendant active groups molecular weight dependence of antibacterial activity. Antimicrob. Agents Chemother. 30: 132-136.
17. Ioannidis, J.P.A., Cappelleri, J.C., Lau, J., Sacks, H.S., and Skolnik, P.R. 1996. Predictive value of viral load measurements in asymptomatic untreated HIV-1 infection: a mathematical model. AIDS 10: 255-262.
18. Katzenstein, T.L., Pedersen, C., Nielsen, C., Lundgren, J.D., Jakobsen, P.M., and Gerstoft, J. 1996. Longitudinal serum HIV RNA quantification: correlation to viral phenotype at seroconversion and clinical outcome. AIDS 10: 167-173.
19. Kucharsky, J., and Safarik, L. 1965. Titrations in non-aqueous solvents, Elsevier, Amsterdam.
20. Letvin, N.L., Daniel, M.D., Sehgal, P.K., Desrosiers, R.C., Hunt, R.D., Waldron, L.M., Mackey, J.J., Schmidt, D.K., Chalifoux, L.V., and King, N.W. 1985. Induction of AIDS-like disease in macaque monkeys with T-cell tropic retrovirus STLV-III. Science 230: 71-73.
21. Levy, J.A., Hoffman, A.D., Kramer, S.M., Landis, J.A., Shimabukuro, J.M., and Oshiro, L.S. 1984. Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS. Science 225: 840-842.
22. Maddon, P.J., Dalgleish, A.G., McDougal, J.S., Clapham, P.R., Weiss, R.A., and Axel, R. 1986. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 47: 333-348.
23. Mann, D.L., Gartner, S., Le Sane, F., Buchow, H., and Popovic, M. 1990. HIV-1 transmission and function of virus-infected monocytes/macrophages. J. Immunol. 144: 2152-2158.
24. Mellors, J.W., Kingsley, L.A., Rinaldo, C.R., Jr., Todd, J.A., Hoo, B.S., Kokka, R.P., and Gupta, P. 1995. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann. Intern. Med. 122: 573-579.
25. Mellors, J.W., Rinaldo, C.R., Gupta, P., White, R.M., Todd, J.A., and Kingsley, L.A. 1996. Prognosis in HIV-1 infection predicted by quantity of virus in plasma. Science 272: 1167-1170.
26. Moore, J.P., Burkly, L.C., Connor, R.I., Cao, Y., Tizard, R., Ho, D.D., and Fisher, R.A. 1993. Adaptation of two primary human immunodeficiency virus type 1 isolates to growth in transformed T cell lines correlates with alteration in the responses of their envelope glycoproteins to soluble CD4. AIDS Res. Hum. Retroviruses 9: 529-539.
27. Munn, R.J., Marx, P.A., Yamamoto, J.K., and Gardner, M.B. 1985. Ultrastructural comparison of the retroviruses associated with human and simian acquired immunodeficiency syndromes. Lab. Invest. 53: 194-199.
28. O'Brien, W.A., Hartigan, P.M., Martin, D., Esinhart, J., Hill, A., Benoit, S., Rubin, M., Simberkoff, M.S., and Hamilton, J.D. 1996. Changes in plasma HIV-1 RNA and CD4 + lymphocyte counts and the risk of progression to AIDS. N. Engl. J. Med. 334: 426-431.
29. Onisi, M., Shimura, K., Seita, Y., and Yamashita, S. 1995. Design of a new plasma separation membrane by graft copolymerization. Radiat. Phys. Chem. 46: 219-223.
30. Onisi, M., Shimura, K., Seita, Y., Yamashita, S., Takahashi, A., and Masuoka, T. 1992. Preparation and properties of plasma-initiated graft copolymerized membranes for blood plasma separation. Radiat. Phys. Chem. 39: 569-570.
31. Owada, T., Miyashita, Y., Motomura, T., Onishi, M., Yamashita, S., and Yamamoto, N. 1998. Enhancement of human immunodeficiency virus type 1 (HIV-1) infection via increased membrane fluidity by a cationic polymer. Microbiol. Immunol. 42: 97-107
32. Perelson, A.S., Neumann, A.U., Markowitz, M., Leonard, J.M., and Ho, D.D. 1996. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271: 1582-1586.
33. Perelson, A.S., Essunger, P., Cao, Y., Vesanen, M., Hurley, A., Saksela, K., Markowitz, M., and Ho, D.D. 1997. Decay characteristics of HIV-1-infected compartments during combination therapy. Nature 387: 188-191.
34. Piatak, M., Jr., Saag, M.S., Yang, L.C., Clark, S.J., Kappes, J.C., Luk, K.C., Hahn, B.H., Shaw, G.M., and Lifson, J.D. 1993. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 259: 1749-1754.
35. Schols, D., Pauwels, R., Desmyter, J., and DeClercq, E. 1990. Dextran sulfate and other polyanionic anti-HIV compounds specifically interact with the viral gp120 glycoprotein expressed by T-cell persistently infected with HIV-1. Virology 175: 556-561.
36. Schols, D., DeClercq, E., Witvrouw, M., Nakashima, H., Snoeck, R., Pauwels, R., Van Schepdael, A., and Claes, P. 1991. Sulphated cyclodextrins are potent anti-HIV agents acting synergistically with 2',3'-dideoxynucleoside analogues. Antiviral Chem. Chemother. 2: 45-53.
37. Stegmann, T., Doms, R.W., and Helenius, A. 1989. Protein-mediated membrane fusion. Annu. Rev. Biochem. 18: 187-211.
38. Tochikura, T.S., Nakashima, H., Ohashi, Y., and Yamamoto, N. 1988. Inhibition (in vitro) of replication and of the cytopathic effect of human immunodeficiency virus by an extract of the culture medium of Lentinus edodes mycelia. Med. Microbiol. Immunol. 177: 235-244.
39. Wei, X., Ghosh, S.K., Taylor, M.E., Johnson, V.A., Emini, E.A., Deutsch, P., Lifson, J.D., Bonhoeffer, S., Nowak, M.A., and Hahn, B.H. 1995. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373: 117-122.